Clinical Trials
14 trialsNCT06499870 2026-06-05
Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
Northwestern University
Phase 2 Recruiting
NCT05624996 2026-05-04
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
NRG Oncology
Phase 3 Recruiting
NCT06532279 2026-05-04
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
NRG Oncology
Phase 2 Recruiting
NCT06378866 2026-04-20
DIVINE
Mayo Clinic
Phase 2 Recruiting
NCT05328505 2026-03-24
MIDAS-Prostate
University Health Network, Toronto
Phase NA Recruiting
NCT07348887 2026-03-04
RTL-DART
University Health Network, Toronto
Phase NA Recruiting
NCT04983095 2026-02-17
METRO
Umeå University
Phase NA Recruiting
NCT06547398 2026-02-05
Prostate Adaptive Radiation Therapy
Royal North Shore Hospital
Phase NA Recruiting
NCT06650033 2026-02-05
Pelvis ART
Royal North Shore Hospital
Phase NA Recruiting
NCT06549478 2025-09-17
Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases
City of Hope Medical Center
Phase 1 Recruiting
NCT06546267 2025-06-11
PROST-ART
IRCCS San Raffaele
Recruiting
NCT06306170 2025-04-22
GYN-ART
IRCCS San Raffaele
Recruiting
NCT06216171 2024-09-27
ProHEART
University Hospital, Essen
Phase NA Recruiting
NCT06330909 2024-03-26
HypoF-SBRT
University Hospital Freiburg
Phase NA Recruiting